| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.6M | +52.0% |
| Cost of Revenue | $545K | +43.4% |
| R&D Expense | $8.2M | +14.0% |
| SG&A Expense | $6.3M | -7.8% |
| Operating Income | -$17.8M | -22.6% |
| Pre-tax Income | -$18.8M | -32.0% |
| Income Tax | $10K | +121.3% |
| Net Income | -$18.8M | -32.1% |
| EPS (Basic) | -$0.85 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.5M | -84.1% |
| Accounts Receivable | $488K | +393.8% |
| Inventory | $3.0M | +356.6% |
| Current Assets | $8.0M | -65.4% |
| Total Assets | $12.4M | -55.2% |
| Current Liabilities | $8.6M | +181.0% |
| Total Liabilities | $10.1M | +7.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$19.4M | -72.4% |
| Capital Expenditures | $762K | +429.3% |
| Investing Cash Flow | -$848K | -489.1% |
| Financing Cash Flow | $2.0M | -90.0% |
| Free Cash Flow | -$20.2M | -76.9% |
| +8.6% |
| EPS (Diluted) | -$0.85 | +8.6% |
| Stockholders' Equity |
| $2.3M |
| -87.4% |